2.251 - 2.275 of 34.391
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Commerzbank Call 60,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 5,34x
- Analysis
- Gilead Sciences Call 200,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 5,33x
- Analysis
- Meta Platforms Call 1.020,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 14,76x
- Analysis
- Moderna Call 24,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 4,57x
- Analysis
- Novo Nordisk Call 475,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,41x
- Analysis
- Novo Nordisk Call 355,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,84x
- Analysis
- Novo Nordisk Call 255,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,29x
- Analysis
- Henkel Vz. Call 72,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 14,86x
- Analysis
- Meta Platforms Call 810,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 22,97x
- Analysis
- Novo Nordisk Call 525,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,31x
- Analysis
- Novo Nordisk Call 415,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,13x
- Analysis
- Novo Nordisk Call 295,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,61x
- Analysis
- Novo Nordisk Call 305,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,71x
- Analysis
- Novo Nordisk Call 275,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,48x
- Analysis
- Novo Nordisk Call 385,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,83x
- Analysis
- Novo Nordisk Call 465,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,44x
- Analysis
- Novo Nordisk Call 395,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,28x
- Analysis
- Novo Nordisk Call 355,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,00x
- Analysis
- Novo Nordisk Call 455,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,35x
- Analysis
- Novo Nordisk Call 325,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,21x
- Analysis
- Novo Nordisk Call 325,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,83x
- Analysis
- Novo Nordisk Call 475,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,88x
- Analysis
- Novo Nordisk Call 365,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,67x
- Analysis
- Novo Nordisk Call 375,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,77x
- Analysis
- Novo Nordisk Call 355,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,52x
- Analysis